172 related articles for article (PubMed ID: 22152544)
1. Developing the evidence base for the new guidelines for reduction of cardiovascular risk for children by the National Heart, Lung, and Blood Institute.
Gidding SS
Cardiol Young; 2011 Dec; 21 Suppl 2():165-8. PubMed ID: 22152544
[TBL] [Abstract][Full Text] [Related]
2. Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute.
Gibbons GH; Shurin SB; Mensah GA; Lauer MS
Circulation; 2013 Oct; 128(15):1713-5. PubMed ID: 23785001
[No Abstract] [Full Text] [Related]
3. The next steps in developing clinical practice guidelines for prevention.
Gibbons GH; Harold JG; Jessup M; Robertson RM; Oetgen WJ
Circulation; 2013 Oct; 128(15):1716-7. PubMed ID: 23929910
[No Abstract] [Full Text] [Related]
4. Developing the 2011 Integrated Pediatric Guidelines for Cardiovascular Risk Reduction.
Gidding SS; Daniels SR; Kavey RE;
Pediatrics; 2012 May; 129(5):e1311-9. PubMed ID: 22492765
[TBL] [Abstract][Full Text] [Related]
5. Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute.
Douglas PS; Taylor A; Bild D; Bonow R; Greenland P; Lauer M; Peacock F; Udelson J
J Cardiovasc Comput Tomogr; 2009; 3(4):212-23. PubMed ID: 19577208
[TBL] [Abstract][Full Text] [Related]
6. Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.
Morimoto T; Fukui T; Lee TH; Matsui K
Am J Med; 2004 Oct; 117(7):459-68. PubMed ID: 15464702
[TBL] [Abstract][Full Text] [Related]
7. International participation in cardiovascular randomized controlled trials sponsored by the National Heart, Lung, and Blood Institute.
Kim ES; Carrigan TP; Menon V
J Am Coll Cardiol; 2011 Aug; 58(7):671-6. PubMed ID: 21816301
[TBL] [Abstract][Full Text] [Related]
8. Developing primary care review criteria from evidence-based guidelines: coronary heart disease as a model.
Hutchinson A; McIntosh A; Anderson J; Gilbert C; Field R
Br J Gen Pract; 2003 Sep; 53(494):690-6. PubMed ID: 15103876
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based child health: SIGN and NICE.
Kelnar CJ
Arch Dis Child Educ Pract Ed; 2008 Dec; 93(6):190-8. PubMed ID: 19028929
[TBL] [Abstract][Full Text] [Related]
10. An evidence-based approach to the development of national dietary guidelines.
Cooper MJ; Zlotkin SH
J Am Diet Assoc; 2003 Dec; 103(12 Suppl 2):S28-33. PubMed ID: 14666497
[TBL] [Abstract][Full Text] [Related]
11. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
12. Screening for sudden cardiac death in the young: report from a national heart, lung, and blood institute working group.
Kaltman JR; Thompson PD; Lantos J; Berul CI; Botkin J; Cohen JT; Cook NR; Corrado D; Drezner J; Frick KD; Goldman S; Hlatky M; Kannankeril PJ; Leslie L; Priori S; Saul JP; Shapiro-Mendoza CK; Siscovick D; Vetter VL; Boineau R; Burns KM; Friedman RA
Circulation; 2011 May; 123(17):1911-8. PubMed ID: 21537007
[No Abstract] [Full Text] [Related]
13. Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute.
Gibbons GH; Shurin SB; Mensah GA; Lauer MS
J Am Coll Cardiol; 2013 Oct; 62(15):1396-8. PubMed ID: 24091225
[No Abstract] [Full Text] [Related]
14. Experts question recommendations for universal lipid screenings in children.
Mitka M
JAMA; 2012 Aug; 308(8):750-1. PubMed ID: 22910740
[No Abstract] [Full Text] [Related]
15. Evaluation of the National Heart, Lung, and Blood Institute guidelines impairment domain for classifying asthma control and predicting asthma exacerbations.
Zeiger RS; Yegin A; Simons FE; Haselkorn T; Rasouliyan L; Szefler SJ; Chipps BE;
Ann Allergy Asthma Immunol; 2012 Feb; 108(2):81-7. PubMed ID: 22289725
[TBL] [Abstract][Full Text] [Related]
16. The next steps in developing clinical practice guidelines for prevention.
Gibbons GH; Harold JG; Jessup M; Robertson RM; Oetgen WJ
J Am Coll Cardiol; 2013 Oct; 62(15):1399-400. PubMed ID: 24091226
[No Abstract] [Full Text] [Related]
17. How to obtain a National Heart, Lung, and Blood Institute-sponsored K08 and K99/R00 grant in the current funding climate.
Houser SR
Circ Res; 2012 Mar; 110(7):907-9. PubMed ID: 22461360
[No Abstract] [Full Text] [Related]
18. Gap between evidence and physicians' knowledge and practice regarding hypertension and its drug treatment: a survey in a Chinese city.
Wang WZ; Tang JL; Hu YH; An JG; Wang YL; Ren ZH; Zhang H; Griffiths S
Chin Med J (Engl); 2011 Apr; 124(8):1235-41. PubMed ID: 21543003
[TBL] [Abstract][Full Text] [Related]
19. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
20. Obesity research and programs at the National Heart, Lung, and Blood Institute.
Simons-Morton DG; Donato K; Loria CM; Pratt CA; Ershow AG; Morrissette MA; Czajkowski S; Arteaga SS; Obarzanek E
J Am Coll Cardiol; 2010 Mar; 55(9):917-20. PubMed ID: 20185044
[No Abstract] [Full Text] [Related]
[Next] [New Search]
